The Fine Print of QIP: Examining OneSource’s Eligibility After Scheme of Arrangement

Facts of the case

• The board of directors of OneSource Specialty Pharma Limited (“OneSource”) unlisted public company which was supposed to get listed pursuant to the proposed transaction, approved a scheme of arrangement amongst

Aniruddha Jain
View all posts